Skip to main content
Clinical Trials/CTRI/2021/03/032164
CTRI/2021/03/032164
Recruiting
未知

Prospective study to evaluate the effects of oral branched chain amino acid supplementation on clinical, laboratory parameters, quality of life and the natural course of the disease in patients with cirrhosis of liver

Max Super Speciality Hospital Vaishali0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: - Health Condition 2: K746- Other and unspecified cirrhosis ofliver
Sponsor
Max Super Speciality Hospital Vaishali
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Max Super Speciality Hospital Vaishali

Eligibility Criteria

Inclusion Criteria

  • 1\-Patients diagnosis with cirrhosis of liver.
  • 2\-Patients who are taking/ who are not taking BCCA supplementation

Exclusion Criteria

  • 1\-Patients on dietary protein restriction
  • 2\-Serum total bilirubin of 3 mg/ dl or higher
  • 3\-Hepatocellular carcinoma
  • 4\-Resistant ascites
  • 5\-Oesohageal varices
  • 6\-Hepato encephalopathy grade III or higher

Outcomes

Primary Outcomes

Not specified

Similar Trials